Copying and distributing are prohibited without permission of the publisher.

Watermark

Grünenthal considers funding options after reports of scrapped leveraged debt sale

pills adobe stock 575x375 pharmaceuticals
By Mike Turner
17 Feb 2021

Grünenthal, the German pain relief medicine maker, has extended the maturities on €535m of term loan facilities, telling GlobalCapital it is open to various financing options, after a press report saying investors had shunned a new euro leveraged loan.

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free Trial
By Mike Turner
17 Feb 2021